Resistance to Targeted Therapies in Breast Cancer

Jenifer R. Prosperi (Hrsg.)

PDF
ca. 166,59
Amazon iTunes Thalia.de Weltbild.de Hugendubel Bücher.de ebook.de kobo Mayersche Osiander Google Books Barnes&Noble bol.com
* Affiliatelinks/Werbelinks
Hinweis: Affiliatelinks/Werbelinks
Links auf reinlesen.de sind sogenannte Affiliate-Links. Wenn du auf so einen Affiliate-Link klickst und über diesen Link einkaufst, bekommt reinlesen.de von dem betreffenden Online-Shop oder Anbieter eine Provision. Für dich verändert sich der Preis nicht.

Springer International Publishing img Link Publisher

Naturwissenschaften, Medizin, Informatik, Technik / Nichtklinische Fächer

Beschreibung

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy.

Weitere Titel zum gleichen Preis
Cover Head and Neck
Enrico Marani
Cover DJ-1/PARK7 Protein
Sanae M. M. Iguchi-Ariga
Cover The Plastic Brain
Rommy von Bernhardi
Cover Personalised Medicine
Sherif El-Khamisy

Kundenbewertungen

Schlagwörter

Angiogenesis, Her2-Targeted Therapy, Targeted Therapy, EGFR Inhibition, Hormone Therapy